JUBILANT PHARMOVA LTD (JUBLPHARMA)

NSE: ₹970.70
BSE: ₹969.75
Stock Performance
Corporate Announcements
Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report

2026-05-27 20:32:59
Earnings Call Transcript

Earnings Call Transcript

2026-05-27 20:24:53
2026-05-23 14:45:56
Tax Demand Order Received By Company's Step Down Subsidiary

Tax Demand order received by company's step down subsidiary

2026-05-22 19:42:36
2026-05-22 14:52:44
2026-05-22 14:41:22

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 217.40 186.30 175.20 205.80 166.70 165.70 196.00 217.30 59.50 66.40 67.30 70.30
YOY Revenue Growth % 8.68% -16.45% -4.13% 2.98% -23.32% -11.06% 11.87% 5.59% -64.31% -59.93% -65.66% -67.65%
Other Income 15.90 18.40 19.00 50.10 19.50 43.80 18.40 17.90 0.70 0.80 0.40 0.50
Total Income 233.30 204.70 194.20 255.90 186.20 209.50 214.40 235.20 60.20 67.20 67.70 70.80
Total Expenses + 231.00 204.50 196.50 214.40 186.20 192.90 205.70 211.70 53.70 58.70 57.60 58.00
Cost of Materials Consumed 71.90 94.90 69.10 74.10 65.50 62.20 76.80 78.00 0.00 0.00 0.00 0.00
Employee Benefit Expense 47.50 46.10 49.90 46.50 48.70 51.40 52.10 50.80 23.20 26.60 29.20 24.80
Other Expenses 60.00 53.30 54.20 55.20 56.30 62.00 56.70 59.80 26.00 28.00 25.90 31.00
Operating Profit -13.60 -18.20 -21.30 -8.60 -19.50 -27.20 -9.70 5.60 5.80 7.70 9.70 12.30
OPM % -6.3% -9.8% -12.2% -4.2% -11.7% -16.4% -4.9% 2.6% 9.7% 11.6% 14.4% 17.5%
Profit Before Tax + 2.30 0.20 -2.30 41.50 -11.20 16.60 8.70 23.50 6.50 8.50 10.10 4.10
Tax Expense 0.40 0.60 0.10 9.00 -1.00 6.10 3.40 9.90 0.70 14.90 3.50 -53.10
Tax % 17.4% 300% - 21.7% - 36.7% 39.1% 42.1% 10.8% 175.3% 34.7% -1295.1%
Profit After Tax 1.90 -0.40 -2.40 32.50 -10.20 10.50 5.30 13.60 5.80 -6.40 6.60 57.20
EPS (Basic) 0.12 -0.03 -0.15 2.05 -0.64 0.66 0.33 0.86 0.36 -0.40 0.42 3.59

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Revenue from Operations 263.50 745.70 784.70 810.12 87.75 2,709.50
YOY Revenue Growth % -64.66% -4.97% -3.14% 823.21% -96.76% -
Other Income 2.40 99.60 103.40 137.89 125.87 47.88
Total Income 265.90 845.30 888.10 948.01 213.62 2,757.38
Total Expenses + 228.00 796.50 846.40 868.67 131.37 2,484.21
Cost of Materials Consumed 0.00 282.50 310.00 396.30 0.00 1,328.92
Employee Benefit Expense 103.80 203.00 190.00 167.27 49.21 220.67
Other Expenses 110.90 234.80 222.70 225.07 45.32 611.41
Operating Profit 35.50 -50.80 -61.70 -58.55 -43.62 225.29
OPM % 13.5% -6.8% -7.9% -7.2% -49.7% 8.3%
Profit Before Exceptional 37.90 48.80 41.70 79.34 82.25 273.17
Exceptional Items -8.70 -11.20 0.00 0.00 0.00 0.00
Profit Before Tax + 29.20 37.60 41.70 79.34 82.25 273.17
Tax Expense -34.00 18.40 10.10 29.46 3.75 58.69
Tax % -116.4% 48.9% 24.2% 37.1% 4.6% 21.5%
Profit After Tax 63.20 19.20 31.60 49.88 78.50 214.48
EPS (Basic) 3.97 1.21 1.99 3.13 4.93 13.47

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
ASSETS
Non-Current Assets + 2,381.80 2,425.40 2,451.30 2,429.59 1,781.57 1,778.35
Property, Plant & Equipment 95.40 514.80 522.60 491.48 99.73 100.06
Capital Work in Progress 5.60 19.30 37.00 46.97 0.06 0.33
Non-Current Investments 2,176.00 1,657.00 1,656.90 1,656.56 1,645.75 1,645.98
Goodwill 0.00 137.10 137.10 137.13 0.00 0.00
Other Intangible Assets 2.50 5.40 1.80 58.79 0.00 27.02
Current Assets + 50.90 484.20 540.60 578.88 47.90 66.25
Inventories 0.00 232.40 250.90 313.60 0.00 0.00
Trade Receivables 23.80 206.30 194.20 188.52 21.23 0.00
Cash and Cash Equivalents 10.30 12.60 36.10 10.99 22.51 40.33
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 2,312.30 2,318.10 2,374.50 2,414.55 1,281.82 1,282.45
Equity Share Capital 15.90 15.90 15.90 15.93 15.93 15.93
Other Equity 2,296.40 2,302.20 2,358.60 2,398.62 1,265.89 1,266.52
Non-Current Liabilities 63.70 281.20 302.00 232.73 509.97 442.00
Current Liabilities 56.70 310.30 315.40 361.19 37.68 120.15
Total Liabilities 120.40 591.50 617.40 593.92 547.65 562.15

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Cash from Operating Activities 93.60 135.60 143.20 -65.12 -6.47 608.38
Cash from Investing Activities 34.00 -2.30 -40.30 31.07 96.02 177.96
Cash from Financing Activities -129.90 -156.80 -77.80 22.51 -107.37 -781.64
Net Increase/Decrease in Cash -2.30 -23.50 25.10 -11.54 -17.82 4.70